Replies to post #2247 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA has committed to releasing some or all of the EDP-235 phase-1 data during the current calendar quarter (i.e. by Jun 30). On the recent CC, Jay Luly was asked whether the initial data release would include all of the dosing cohorts or just some of them, and he said that the decision hadn’t yet been made.